Brought to you by 
Essex Woodlands makes equity investment in Endologix
18 Nov 2010
Executive Summary
Concurrent with Endologix Inc.'s (minimally invasive aortic disorder treatments) acquisition of Nellix Endovascular Inc., Essex Woodlands Health Ventures has made an equity investment of $15mm in Endologix, giving it a 6% stake in the company. Essex, which was a majority shareholder in Nellix and will now contribute two board members to Endologix, has paid $4.73 (a 6% discount) for 3.17mm common shares.
Deal Industry
- Medical Devices
-
Medical Devices
- Implantable Devices
-
Surgical Equipment & Devices
- Minimally or Less Invasive
Deal Status
- Final
Deal Type
-
Financing
- Private Placement
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Essex Woodlands makes equity investment in Endologix
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice